Vascular tumors (hemangioma) and malformations (venous, lymphatic and arteriovenous) represent a group of entities with a confusing terminology. Lack of knowledge and poorly understood diagnostic criteria can easily lead to incorrect triaging and mistreatment.

摘要

Current management of hemangiomas has dramatically changed in the last two years and beta-blockers therapy will allow in the not too distant future a significant reduction of surgical indications.There is no indication for sclerotherapy in hemangiomas management but is clearly the first option to consider for venous malformations treatment . Endovascular obliteration with dyode laser, is becoming an extremely useful tool in treating the venous dilatation. Arteriovenous malformations remain as the most challenging vascular anomalies to treat and multidisciplinary approach is needed to achieve a successful outcome. Lymphatic malformations can display a microcystic or macrocystic pattern . Surgery, sclerotherapy (OK-432, bleomicine or doxycicline) and rapamycine comprise the current therapeutical options .